CytoSorbents Hits Financial Milestone in Q3 2026
CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...
Continue Reading